RxDoctor Payments Data

Jeffrey Sewecke, DO

Adult Reconstructive Orthopaedic Surgery · Pittsburgh, PANPI 1487655544

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.2%), royalties or licence payments and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Globus Medical at 60.0% of the total. Reporting peaked in 2019 at $24,599 and has fallen 55.5% since, to $10,934 in 2025.

$84,240in general payments, 2019–2025

Across 74 payments — averaging $1138.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$51K
  • Kyocera Medical Technologies, Inc.$18K
  • Renovis Surgical Technologies, Inc.$14K
  • Johnson & Johnson$627
  • Stryker$495
  • Zimmer Biomet$257
  • plus $428 from 6 others

What the payments were for

  • Royalty or licence$31,93238%
  • Consulting fees$39,77547%
  • Speaking & faculty fees$3,8005%
  • Travel & lodging$6,7008%
  • Food & beverage$2,0332%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$84,240 in reported general payments places this provider in the 80th percentile of 51 adult reconstructive orthopaedic surgery providers in Pennsylvania.

See all adult reconstructive orthopaedic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$214,092
Medicare patients
313
Services billed
9,374

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib20$301
Methylprednisolone39$267
Amoxicillin209$213
Mupirocin24$165
Meloxicam13$70
Clindamycin Hcl55$69

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →